Carmell Therapeutics (CTCX)
NASDAQ:CTCX
US Market
Holding CTCX?
Track your performance easily

Carmell Therapeutics (CTCX) Financial Statements

19 Followers

Carmell Therapeutics Financial Overview

Carmell Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.56; its P/E ratio is -0.55; Carmell Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 12.32K-$ 3.73M--
Gross Profit$ 12.03K-$ 2.18M--
EBIT$ -3.30M$ -468.93K$ -11.46M$ 706.14K$ 919.39K
EBITDA$ -3.24M$ -397.89K$ -10.97M$ 706.14K$ 919.39K
Net Income Common Stockholders$ -3.30M$ -3.27M$ -11.51M$ 772.85K$ 413.14K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.20M$ 892.16K$ 7.97M$ 10.24K$ 16.13K
Total Assets$ 5.03M$ 6.18M$ 82.22M$ 160.30M$ 158.50M
Total Debt$ 798.74K$ 1.54M$ 882.01K$ 0.00$ 0.00
Net Debt$ -1.40M$ 652.18K$ -7.09M$ -10.24K$ -16.13K
Total Liabilities$ 6.41M$ 7.57M$ 61.31M$ 4.11M$ 2.62M
Stockholders Equity$ -1.37M$ -1.39M$ 20.92M$ -2.40M$ -1.31M
Cash Flow-
Free Cash Flow$ -1.14M$ -1.08M$ -5.06M$ -5.89K$ -171.53K
Operating Cash Flow$ -1.14M$ -1.08M$ -5.03M$ -5.89K$ -171.53K
Investing Cash Flow-$ -748.80K$ 632.53K--
Financing Cash Flow$ 2.44M$ -195.73K$ 12.41M--
Currency in USD

Carmell Therapeutics Earnings and Revenue History

Carmell Therapeutics Debt to Assets

Carmell Therapeutics Cash Flow

Carmell Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis